SBI Securities’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$141K Sell
10,403
-3,202
-24% -$38.3K ﹤0.01% 785
2026
Q1
$81.5K Sell
13,605
-426
-3% -$3.21K ﹤0.01% 912
2025
Q4
$101K Buy
14,031
+5,431
+63% +$42.9K ﹤0.01% 849
2025
Q3
$91.8K Sell
8,600
-1,560
-15% -$15.3K ﹤0.01% 875
2025
Q2
$98.3K Buy
10,160
+2,507
+33% +$25.9K ﹤0.01% 826
2025
Q1
$114K Buy
7,653
+1,145
+18% +$17.6K ﹤0.01% 702
2024
Q4
$97.1K Buy
+6,508
New +$106K ﹤0.01% 764

Other funds holding OGN

SBI Securities's OGN Position: Q2 2026 in Review

SBI Securities reduced its Organon & Co (OGN) stake by 24% in Q2 2026, selling an estimated $38.3K and leaving 10,403 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #785.

SBI Securities first reported a position in OGN in Q4 2024 and has held it in 7 quarters since. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • SBI Securities held 10,403 shares of Organon & Co worth $141K as of Q2 2026.
  • SBI Securities sold 3,202 Organon & Co shares in Q2 2026, an estimated $38.3K.
  • Organon & Co made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #785 holding.
  • SBI Securities first reported a position in Organon & Co in Q4 2024 and has held it in 7 quarters since.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.